Osteopontin Levels in Patients With Chronic Kidney Disease Stage 5 on Hemodialysis Directly Correlate With Intact Parathyroid Hormone and Alkaline Phosphatase

Overview

Journal Clin Appl Thromb Hemost

Publisher Sage Publications

Specialty Cardiology & Vascular Diseases

Date 2019 Dec 27

PMID 31876180

Citations 2

Authors

Aleksander Druck

Dimpi Patel

Vinod Bansal

Debra Hoppensteadt

Jawed Fareed

Affiliations

Soon will be listed here.

Abstract

Chronic kidney disease stage 5 (CKD5) marks the fifth stage of renal failure, frequently causing dysregulation of bone and mineral metabolism. Challenges exist in evaluating and managing chronic kidney disease-mineral bone disorder (CKD-MBD) with the standard panel of biomarkers. Our objective was to profile osteopontin (OPN) in patients with CKD5 on maintenance hemodialysis (CKD5-HD) and elucidate its relationship to phosphorus (P), calcium (Ca), alkaline phosphatase (AP), and intact parathyroid hormone (iPTH) to improve understanding of the present model of CKD-MBD. Elevation of plasma OPN was seen in the CKD5-HD cohort (n = 92; median: 240.25 ng/mL, interquartile range [IQR]: 169.85 ng/mL) compared to a normal group (n = 49; median: 63.30 ng/mL, IQR: 19.20 ng/mL; < .0001). Spearman correlation tests revealed significant positive correlations of OPN with iPTH ( < .0001; = 0.561, 95% confidence interval = 0.397-0.690) and OPN with AP ( < .0001; = 0.444, 95% confidence interval = 0.245-0.590) in CKD5-HD patients. Ultimately, OPN may play an integral role in the MBD axis, suggesting that it may be important to actively monitor OPN when managing CKD5-HD.

Citing Articles

Osteopontin as a Biomarker in Chronic Kidney Disease.

Sinha S, Mellody M, Carpio M, Damoiseaux R, Nicholas S Biomedicines. 2023; 11(5).

PMID: 37239027 PMC: 10216241. DOI: 10.3390/biomedicines11051356.

Vitamin D3 Repletion Improves Vascular Function, as Measured by Cardiorenal Biomarkers in a High-Risk African American Cohort.

Sinha S, Sun L, Didero M, Martins D, Norris K, Lee J Nutrients. 2022; 14(16).

PMID: 36014837 PMC: 9414215. DOI: 10.3390/nu14163331.

References

Shen Q, Christakos S . The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin. J Biol Chem. 2005; 280(49):40589-98. DOI: 10.1074/jbc.M504166200. View

Blayney M, Pisoni R, Bragg-Gresham J, Bommer J, Piera L, Saito A . High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and death. Kidney Int. 2008; 74(5):655-63. DOI: 10.1038/ki.2008.248. View

. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl (2011). 2019; 7(1):1-59. PMC: 6340919. DOI: 10.1016/j.kisu.2017.04.001. View

Icer M, Gezmen-Karadag M . The multiple functions and mechanisms of osteopontin. Clin Biochem. 2018; 59:17-24. DOI: 10.1016/j.clinbiochem.2018.07.003. View

Liu H, Chen A, Guo F, Yuan L . Influence of osteopontin short hairpin RNA on the proliferation and invasion of human renal cancer cells. J Huazhong Univ Sci Technolog Med Sci. 2010; 30(1):61-8. DOI: 10.1007/s11596-011-0111-7. View

Scatena M, Liaw L, Giachelli C . Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol. 2007; 27(11):2302-9. DOI: 10.1161/ATVBAHA.107.144824. View

Fried L, Biggs M, Shlipak M, Seliger S, Kestenbaum B, Stehman-Breen C . Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol. 2006; 18(1):282-6. DOI: 10.1681/ASN.2006050546. View

Uz O, Kardesoglu E, Yiginer O, Bas S, Ipcioglu O, Ozmen N . The relationship between coronary calcification and the metabolic markers of osteopontin, fetuin-A, and visfatin. Turk Kardiyol Dern Ars. 2009; 37(6):397-402. View

Yuan Q, Sato T, Densmore M, Saito H, Schuler C, Erben R . Deletion of PTH rescues skeletal abnormalities and high osteopontin levels in Klotho-/- mice. PLoS Genet. 2012; 8(5):e1002726. PMC: 3355080. DOI: 10.1371/journal.pgen.1002726. View

10.

Tonelli M, Wiebe N, Guthrie B, James M, Quan H, Fortin M . Comorbidity as a driver of adverse outcomes in people with chronic kidney disease. Kidney Int. 2015; 88(4):859-66. DOI: 10.1038/ki.2015.228. View

11.

Wei Q, Huang L, Tan X, Chen Z, Chen S, Deng W . Serum osteopontin levels in relation to bone mineral density and bone turnover markers in postmenopausal women. Scand J Clin Lab Invest. 2015; 76(1):33-9. DOI: 10.3109/00365513.2015.1087045. View

12.

Chellaiah M, Hruska K . The integrin alpha(v)beta(3) and CD44 regulate the actions of osteopontin on osteoclast motility. Calcif Tissue Int. 2002; 72(3):197-205. DOI: 10.1007/s00223-002-1025-6. View

13.

Lund S, Giachelli C, Scatena M . The role of osteopontin in inflammatory processes. J Cell Commun Signal. 2009; 3(3-4):311-22. PMC: 2778587. DOI: 10.1007/s12079-009-0068-0. View

14.

Portale A, Halloran B, Morris Jr R . Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D. J Clin Invest. 1987; 80(4):1147-54. PMC: 442358. DOI: 10.1172/JCI113172. View

15.

Lomashvili K, Cobbs S, Hennigar R, Hardcastle K, ONeill W . Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. J Am Soc Nephrol. 2004; 15(6):1392-401. DOI: 10.1097/01.asn.0000128955.83129.9c. View

16.

Xu A, Bai J, Lu J, Liang Y, Li J, Lai D . Osteopontin gene polymorphism in association with systemic lupus erythematosus in Chinese patients. Chin Med J (Engl). 2008; 120(23):2124-8. View

17.

Abdalrhim A, Marroush T, Austin E, Gersh B, Solak N, Rizvi S . Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial. PLoS One. 2016; 11(6):e0156965. PMC: 4902195. DOI: 10.1371/journal.pone.0156965. View

18.

Wai P, Kuo P . Osteopontin: regulation in tumor metastasis. Cancer Metastasis Rev. 2007; 27(1):103-18. DOI: 10.1007/s10555-007-9104-9. View

19.

Denhardt D, Guo X . Osteopontin: a protein with diverse functions. FASEB J. 1993; 7(15):1475-82. View

20.

Wong C, Lit L, Tam L, Li E, Lam C . Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2005; 44(5):602-6. DOI: 10.1093/rheumatology/keh558. View